Antibodies to type III group B streptococcal polysaccharide in breast milk

Pediatric Infectious Disease Journal

Volumn 23, Issue 10, 2004, Pages 961-963

  Edwards, Morven S ^a   Munoz, Flor M ^a   Baker, Carol J ^a  

^a BAYLOR COLLEGE OF MEDICINE   (United States)

Author keywords

Antibody; Breast milk; Group B Streptococcus

Indexed keywords

IMMUNOGLOBULIN A; IMMUNOGLOBULIN G; STREPTOCOCCUS ANTIGEN; BACTERIAL POLYSACCHARIDE; BACTERIUM ANTIBODY; STREPTOCOCCAL POLYSACCHARIDE TYPE III GROUP B;

ANTIBODY MILK LEVEL; ANTIBODY PRODUCTION; ARTICLE; BREAST MILK; CLINICAL ARTICLE; CONTROLLED STUDY; FEMALE; HUMAN; HUMAN EXPERIMENT; MILK LEVEL; NORMAL HUMAN; PRIORITY JOURNAL; PUERPERIUM; STREPTOCOCCUS; STREPTOCOCCUS INFECTION; ADULT; BREAST FEEDING; IMMUNOLOGY; NEUTROPHIL; RETROSPECTIVE STUDY; STREPTOCOCCUS AGALACTIAE;

ADULT; ANTIBODIES, BACTERIAL; BREAST FEEDING; FEMALE; HUMANS; IMMUNOGLOBULIN A; IMMUNOGLOBULIN G; MILK, HUMAN; NEUTROPHILS; POLYSACCHARIDES, BACTERIAL; RETROSPECTIVE STUDIES; STREPTOCOCCUS AGALACTIAE;

EID: 16544376682     PISSN: 08913668     EISSN: None     Source Type: Journal    
DOI: 10.1097/01.inf.0000142333.72511.8c     Document Type: Article

References (11)

1. Schrag SJ, Zywicki S, Farley MM, et al. Group B streptococcal disease in the era of intrapartum antibiotic prophylaxis. N Engl J Med. 2000; 342:15-20.
2. Harrison LH, Elliott JA, Dwyer DM, et al. Serotype distribution of invasive group B streptococcal isolates in Maryland: implication for vaccine formulation. J Infect Dis. 1998;177:998-1002.
3. Munoz FM, Piedra PA, Glezen WP. Safety and immunogenicity of respiratory syncytial virus purified fusion protein-2 vaccine in pregnant women. Vaccine. 2003;21:3465-3467.
4. Guttormsen HK, Baker CJ, Edwards MS, Paoletti LC, Kasper DL. Quantitative determination of antibodies to type III group B streptococcal polysaccharide. J Infect Dis. 1996;173:142-150.
5. Hall MA, Edwards MS, Baker CJ. Complement and antibody participation in opsonophagocytosis of type IV and V group B streptococci. Infect Immun. 1992;60:5030-5035.
6. Goldblum RM, Hanson LA, Brandtzaeg P. The mucosal defense system. In: Stiehm ER, ed. Immunologic Disorders in Infants and Children. 4th ed. Philadelphia, PA: W. B. Saunders; 1996:159-199.
7. Lagergard T, Thiringer K, Wassen L, Schneerson R, Trollfors B. Isotype composition of antibodies to Streptococcus group B type III polysaccharide and to tetanus toxoid in maternal, cord blood sera and in breast milk. Eur J Pediatr. 1992;151:98-102.
8. Weisman LE, Dobson FM. The potential impact of group B streptococcal antibodies in breast milk. In: Immunology of Milk and the Neonate. New York, NY: Plenum Press; 1991:345-351.
9. Finn A, Zhang Q, Seymour L, Fasching C, Pettitt E, Janoff EN. Induction of functional secretory IgA responses in breast milk, by pneumococcal capsular polysaccharides. J Infect Dis. 2002;186:1422-1429.
10. Shahid NS, Steinhoff MC, Roy E, Begum T, Thompson CM, Siber GR. Placental and breast transfer of antibodies after maternal immunization with polysaccharide meningococcal vaccine: a randomized, controlled evaluation. Vaccine. 2002;20:2404-2409.
11. Munoz FM, Englund JA, Cheesman CC, et al. Maternal immunization with pneumococcal polysaccharide vaccine in the third trimester of gestation. Vaccine. 2001;20:826-837.